KROMASURE
Live / Applied — Non-final action mailed (as of 31 Oct 2025)
What this means for you
Not registered yet, but its 03 Jun 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99215721
- Mark type
- Stylized text
- Filed
- 03 Jun 2025
- Attorney of record
- Amanda H. Wilcox
Goods and services
- Class 001 — Chemicals: Assays and reagents for use in genetic research; Assays for research purposes; Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents to monitor toxicity of drugs; Diagnostic preparations for clinical or medical laboratory use; Diagnostic preparations for scientific or research use; Diagnostic preparations for scientific use; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for scientific or research use; Diagnostic reagents for scientific use; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for clinical or medical laboratory use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology fields; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use
- Class 005 — Pharmaceuticals: Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Cells for medical use; Clinical medical reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection; Diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; Immunoassay reagents for medical use; Culture media for cultivating human blood cells; Solutions for medical and clinical use in storing and treating cells, blood and blood components; Stem cells for medical or veterinary use; Stem cells for medical purposes
- Class 010 — Medical apparatus: Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing
- Class 035 — Advertising and business services: Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting and management in the field of clinical trials, namely, providing information management services
- Class 042 — Scientific and technological services: Custom design and development of chemical reagents and biochemical assays; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research in the field of oncology; Medical research services; Scientific research; Scientific research and development; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Genetic testing for scientific research purposes; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases
- Class 044 — Medical, beauty and agricultural services: DNA screening for medical purposes
Owner
- Kromatid Inc., LONGMONT, CO, US
Prosecution history
- 30 Jan 2026 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 30 Jan 2026 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 31 Oct 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 31 Oct 2025 — NON-FINAL ACTION E-MAILED
- 31 Oct 2025 — NON-FINAL ACTION WRITTEN
- 23 Oct 2025 — ASSIGNED TO EXAMINER
- 17 Oct 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 03 Jun 2025 — APPLICATION FILING RECEIPT MAILED
- 03 Jun 2025 — NEW APPLICATION ENTERED